Latest On Colfax Corporation (CFXA):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2022-01-13 05:05 EST | Dividend | A dividend of $1.44 has been announced on Dec 20, 2021. It will be paid Jan 15, 2022 with an ex-dividend date of Jan 13, 2022. | Neutral |  |
| 2021-11-23 14:11 EST | News | Colfax (CFX) Presents At Credit Suisse 30th Annual Healthcare Conference - Slideshow | N/A | |
| 2021-11-08 04:18 EST | News | Colfax Corporation's (CFX) CEO Matt Trerotola on Q3 2021 Results - Earnings Call Transcript | N/A | |
| 2021-11-07 06:46 EST | News | Colfax Corporation 2021 Q3 - Results - Earnings Call Presentation | N/A | |
| 2021-10-13 06:05 EST | Dividend | A dividend of $1.44 has been announced on Sep 9, 2021. It will be paid Oct 15, 2021 with an ex-dividend date of Oct 13, 2021. | Neutral | |
| 2021-08-15 15:29 EST | News | Colfax: Setup Turns Compelling Heading Into The Upcoming Separation Event | N/A | |
| 2021-07-30 06:53 EST | News | Colfax Corporation 2021 Q2 - Results - Earnings Call Presentation | N/A | |
| 2021-07-30 06:53 EST | News | Colfax Corp (CFX) CEO Matthew Trerotola on Q2 2021 Results - Earnings Call Transcript | N/A | |
| 2021-07-13 06:08 EST | Dividend | A dividend of $1.44 has been announced on Jun 11, 2021. It will be paid Jul 15, 2021 with an ex-dividend date of Jul 13, 2021. | Neutral | |
| 2021-05-02 18:08 EST | News | Colfax's (CFX) CEO Matt Trerotola on Q1 2021 Results - Earnings Call Transcript | N/A | |
| 2021-05-01 00:45 EST | News | Colfax Corporation 2021 Q1 - Results - Earnings Call Presentation | N/A | |
| 2021-04-13 06:05 EST | Dividend | A dividend of $1.44 has been announced on Mar 11, 2021. It will be paid Apr 15, 2021 with an ex-dividend date of Apr 13, 2021. | Neutral | |
| 2021-02-19 21:43 EST | Financials | Company financials have been released. | Neutral | |
| 2021-02-19 02:54 EST | News | Colfax Corporation (CFX) CEO Matt Trerotola on Q4 2020 Results - Earnings Call Transcript | N/A | |
| 2021-01-13 05:09 EST | Dividend | A dividend of $1.44 has been announced on Dec 17, 2020. It will be paid Jan 15, 2021 with an ex-dividend date of Jan 13, 2021. | Neutral | |
| 2020-12-04 18:11 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-26 23:33 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-12 12:56 EST | News | Colfax (CFX) Presents At Credit Suisse 29th Annual Virtual Healthcare Conference - Slideshow | N/A | |
| 2020-11-08 02:29 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-07 18:50 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-07 14:00 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-06 22:23 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-01 09:55 EST | News | Colfax Corporation 2020 Q3 - Results - Earnings Call Presentation | N/A | |
| 2020-11-01 09:55 EST | News | Colfax Corporation (CFX) CEO Matt Trerotola on Q3 2020 Results - Earnings Call Transcript | N/A | |
| 2020-10-13 06:03 EST | Dividend | A dividend of $1.44 has been announced on Jun 11, 2020. It will be paid Oct 15, 2020 with an ex-dividend date of Oct 13, 2020. | Neutral | |
| 2020-09-26 15:41 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-20 05:05 EST | News | Colfax (CFX) Presents At Morgan Stanley Virtual 8th Annual Laguna Conference - Slideshow | N/A | |
| 2020-09-17 08:05 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-14 11:45 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-12 14:58 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-11 14:57 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-09 05:43 EST | News | Colfax's (CFX) CEO Matt Trerotola on Q2 2020 Results - Earnings Call Transcript | N/A | |
| 2020-08-08 08:37 EST | News | Colfax Corporation 2020 Q2 - Results - Earnings Call Presentation | N/A | |
| 2020-08-06 15:23 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-31 11:12 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-30 19:32 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-30 07:31 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-29 23:45 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-28 17:16 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-27 15:22 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-23 20:12 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-13 06:02 EST | Dividend | A dividend of $1.44 has been announced on Jun 11, 2020. It will be paid Jul 15, 2020 with an ex-dividend date of Jul 13, 2020. | Neutral | |
| 2020-07-09 11:34 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-01 19:15 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-01 03:05 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-19 15:08 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-14 07:17 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-12 08:51 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-27 07:55 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-21 10:43 EST | Financials | Company financials have been released. | Neutral | |
About Colfax Corporation (CFXA):
Colfax Corporation operates as a diversified technology company worldwide. The company operates in two segments, Fabrication Technology and Medical Technology. The Fabrication Technology segment formulates, develops, manufactures, and supplies consumable products and equipment, including cutting, joining, and automated welding products, as well as gas control equipment. It also provides welding consumables comprising electrodes, cored and solid wires, and fluxes using a range of specialty and other materials; and cutting consumables, such as electrodes, nozzles, and shields and tips. This segment sells its products through independent distributors and direct sales to the infrastructure, wind power, marine/life sciences, pipelines, mobile/off-highway equipment, oil, gas, and mining markets principally under the ESAB brand. The Medical Technology segment develops, manufactures, and distributes medical device products used by orthopedic specialists, spine surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries. It offers rigid and soft orthopedic bracings, hot and cold therapy products, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators used for pain management, and physical therapy products; and a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger. This segment sells its products through independent distributors, such as healthcare professionals, consumer retail stores, and pharmacies; and direct and independent distributors under the DJO brand. Colfax Corporation was founded in 1860 and is headquartered in Annapolis Junction, Maryland.
General
- Name Colfax Corporation
- Symbol CFXA
- Type Common Stock
- Exchange NYSE
- Currency USD
- Country USA
- SectorIndustrials
- IndustrySpecialty Industrial Machinery
- Full Time Employees 15,400
- Fiscal Year EndDecember
- IPO Date2019-01-09
- Gic SectorIndustrials
- Gic GroupCapital Goods
- Gic IndustryMachinery
- Web URLhttp://www.colfaxcorp.com
Valuation
- Trailing PE 595.13
Financials
- Most Recent Quarter 2020-12-31
- Profit Margin 1%
- Operating Margin 7%
- Return on Assets 2%
- Return on Equity 2%
- Revenue 3.07 billion
- Earnings Per Share $0.31
- Revenue Per Share $22.45
- Quarterly Earnings Growth -6.8%
Highlights
- Market Capitalization 4.72 billion
- EBITDA 453.83 million
- Book Value Per Share $29.90
Share Statistics
- Shares Outstanding 117.2 million
- Shares Float 101.62 million
- % Held by Insiders <1%
- % Held by Institutions 98.57%
- Shares Short 7028
- Shares Short Prior Month 14603
- Short Ratio 0.38
Technicals
- Beta 2.24
- 52 Week High $205.31
- 52 Week Low $67.12
- 50 Day Moving Average 179.45
- 200 Day Moving Average 154.49
Dividends
- Forward Annual Dividend Yield 5.59%
- Payout Ratio 1807%
- Dividend Date 2021-04-15
- ExDividend Date N/A
- Dividend Yield 3.2%
Colfax Corporation (CFXA) Dividend Calendar:
CFXA's last dividend payment was made to shareholders on April 15, 2021.
Colfax Corporation pays out 1807% of its earnings out as a dividend.
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Colfax Corporation (CFXA) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-09-30 | 2020-12-31 | $805.93 million | $0.29 | $0.00 | |
| 2020-06-30 | 2020-07-03 | $620.36 million | -$0.03 | $0.05 | -160% |
| 2020-03-31 | 2020-04-03 | $816.36 million | $0.06 | $0.37 | -84.49% |
| 2019-12-31 | 2020-02-21 | $888.37 million | $0.61 | $0.56 | 8.93% |
| 2019-09-30 | 2019-12-31 | $N/A | $0.23 | $0.47 | -50.91% |
| 2019-06-30 | 2019-09-27 | $N/A | $0.01 | $0.61 | -98.25% |
| 2019-03-31 | 2019-06-28 | $N/A | $-0.00 | $0.49 | -100.71% |
| 2018-12-31 | 2019-03-29 | $574.93 million | -$0.19 | $0.63 | -130.48% |
| 2018-09-30 | 2018-12-31 | $0.29 | $0.53 | -45.4% | |
| 2018-06-30 | 2018-09-28 | $0.10 | $0.52 | -80.1% | |
| 2018-03-31 | 2018-06-29 | $0.36 | $0.42 | -14.45% | |
| 2017-12-31 | 2018-03-30 | $0.13 | $0.44 | -70.09% | |
| 2017-09-30 | 2017-11-06 | $0.42 | $0.41 | 2.44% | |
| 2017-06-30 | 2017-09-29 | $0.35 | $0.43 | -18.6% | |
| 2017-03-31 | 2017-06-30 | $0.30 | $0.30 | -0.47% | |
| 2016-12-31 | 2017-03-31 | $0.29 | $0.44 | -34.55% | |
| 2016-09-30 | 2016-12-31 | $0.31 | $0.35 | -11.43% | |
| 2016-06-30 | 2016-09-30 | $0.30 | $0.39 | -24.18% | |
| 2016-03-31 | 2016-04-01 | $0.18 | $0.27 | -33.33% | |
| 2015-12-31 | 2016-02-04 | $0.51 | $0.43 | 18.6% | |
| 2015-09-30 | 2015-12-31 | $0.35 | $0.41 | -14.61% | |
| 2015-06-30 | 2015-09-25 | $0.15 | $0.48 | -69.25% | |
| 2015-03-31 | 2015-06-26 | $0.42 | $0.33 | 27.27% | |
| 2014-12-31 | 2015-03-27 | $0.42 | $0.64 | -34.38% | |
| 2014-09-30 | 2014-12-31 | $0.64 | $0.61 | 5.62% | |
| 2014-06-30 | 2014-09-26 | $0.59 | $0.66 | -10.61% | |
| 2014-03-31 | 2014-06-27 | $1.53 | $0.44 | 247.73% | |
| 2013-12-31 | 2014-03-28 | $0.22 | $0.59 | -62.71% | |
| 2013-09-30 | 2013-12-31 | $0.28 | $0.53 | -47.06% | |
| 2013-06-30 | 2013-09-27 | $0.48 | $0.53 | -9.28% | |
| 2013-03-31 | 2013-06-28 | $0.52 | $0.24 | 118.17% | |
| 2012-12-31 | 2013-03-29 | $0.21 | $0.39 | -46.51% | |
| 2012-09-30 | 2012-12-31 | $0.14 | $0.31 | -55.9% | |
| 2012-06-30 | 2012-09-28 | $0.04 | $0.36 | -89.64% | |
| 2012-03-31 | 2012-06-29 | $0.07 | $0.20 | -66.15% | |
| 2011-12-31 | 2012-03-30 | -$1.33 | $0.45 | -396.56% | |
| 2011-09-30 | 2011-12-31 | -$0.37 | $0.30 | -223.4% | |
| 2011-06-30 | 2011-09-30 | $0.08 | $0.26 | -69.23% | |
| 2011-03-31 | 2011-04-01 | $0.15 | $0.20 | -25% | |
| 2010-12-31 | 2011-02-15 | $0.39 | $0.33 | 18.18% | |
| 2010-09-30 | 2010-12-31 | $0.20 | $0.19 | 5% | |
| 2010-06-30 | 2010-07-28 | $0.18 | $0.16 | 12.5% | |
| 2010-03-31 | 2010-04-30 | $0.13 | $0.10 | 30% | |
| 2009-12-31 | 2010-02-18 | $0.26 | $0.24 | 8.33% | |
| 2009-09-30 | 2009-11-03 | $0.23 | $0.20 | 15% | |
| 2009-06-30 | 2009-08-04 | $0.20 | $0.25 | -20% | |
| 2009-03-31 | 2009-05-08 | $0.24 | $0.24 | 0% | |
| 2008-12-31 | 2009-02-20 | $0.40 | $0.32 | 25% | |
| 2008-09-30 | 2008-11-05 | $0.28 | $0.28 | 0% | |
| 2008-06-30 | 2008-08-05 | $0.32 | $0.28 | 14.29% |
Colfax Corporation (CFXA) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date | Dec 31 2020 | Sep 30 2020 | Jun 30 2020 | Apr 3 2020 | Mar 31 2020 |
|---|---|---|---|---|---|
| Research Development | N/A | N/A | N/A | N/A | N/A |
| Income Before Tax | 32.83 million | 36.36 million | -33.21 million | 22.04 million | 22.04 million |
| Selling General Administrative | 281.42 million | 278.06 million | 235.73 million | 291.3 million | 291.3 million |
| Gross Profit | 354.69 million | 344.12 million | 241.09 million | 350.01 million | 348.21 million |
| Ebit | 123.56 million | 123.01 million | 56.78 million | N/A | 105.17 million |
| Operating Income | 73.27 million | 66.06 million | 5.36 million | 46.84 million | 56.92 million |
| Income Tax Expense | N/A | N/A | N/A | N/A | N/A |
| Total Revenue | 828.12 million | 805.93 million | 620.36 million | 816.36 million | 816.36 million |
| Cost of Revenue | 473.44 million | 461.81 million | 379.27 million | 466.34 million | 468.14 million |
| Total Other Income Expense Net | -14.82 million | -4.13 million | -10.28 million | N/A | -10.08 million |
| Net Income From Continuing Operations | 41.52 million | 16.84 million | -3.14 million | N/A | 8.87 million |
| Net Income Applicable to Common Shares | N/A | N/A | N/A | 4.48 million | N/A |
Cash Flow:
| Date | Sep 30 2020 | Jun 30 2020 | Apr 3 2020 | Mar 31 2020 | Dec 31 2019 |
|---|---|---|---|---|---|
| Investments | -31.15 million | -15.72 million | N/A | -37.26 million | 1.6 billion |
| Change to Liabilities | N/A | N/A | N/A | N/A | N/A |
| Total Cash Flow from Investing Activities | N/A | N/A | -37.26 million | N/A | N/A |
| Net Borrowings | N/A | N/A | N/A | N/A | N/A |
| Total Cash Flow from Financial Activities | -48.17 million | -322.55 million | 245.14 million | 245.14 million | -1.72 billion |
| Change to Operating Activities | N/A | N/A | N/A | N/A | N/A |
| Change in Cash | 27000 | -299.21 million | 255.97 million | 255.97 million | -57.13 million |
| Total Cash from Operating Activities | 79.92 million | 36.99 million | 56.23 million | 56.23 million | N/A |
| Depreciation | 61.08 million | 61.7 million | 58.34 million | 58.34 million | 45.45 million |
| Other Cash Flow from Investing Activities | N/A | N/A | -6.14 million | N/A | N/A |
| Change to Inventory | 28.2 million | 16.78 million | N/A | -16.43 million | 9.37 million |
| Change to Account Receivables | -44.64 million | 59.79 million | N/A | 29.45 million | 20.85 million |
| Other Cash Flow from Financing Activities | N/A | N/A | -1.35 million | N/A | N/A |
| Change to Net Income | N/A | N/A | N/A | N/A | N/A |
| Capital Expenditures | 31.16 million | 19.31 million | 31.11 million | 31.11 million | 25.02 million |
Balance Sheet:
| Date | Dec 31 2020 | Sep 30 2020 | Jun 30 2020 | Apr 3 2020 | Mar 31 2020 |
|---|---|---|---|---|---|
| Total Liabailities | 3.76 billion | 3.7 billion | 3.73 billion | 4.16 billion | 4.12 billion |
| Total Stockholder Equity | 3.54 billion | 3.41 billion | 3.35 billion | 3.29 billion | 3.29 billion |
| Other Current Liabilities | N/A | N/A | N/A | N/A | N/A |
| Total Assets | 7.35 billion | 7.15 billion | 7.12 billion | 7.46 billion | 7.46 billion |
| Common Stock | N/A | N/A | N/A | 118000 | N/A |
| Other Current Assets | 113.42 million | 186.68 million | 155.63 million | 154.93 million | 154.93 million |
| Retained Earnings | 517.37 million | 484.16 million | 470.75 million | 479.22 million | 479.22 million |
| Other Liabilities | N/A | N/A | N/A | N/A | N/A |
| Other Assets | N/A | N/A | N/A | 392.08 million | N/A |
| Cash | 97.07 million | 66.42 million | 66.4 million | 365.6 million | 365.6 million |
| Total Current Liabilities | 811.66 million | 784.53 million | 758.73 million | 819.1 million | 819.1 million |
| Other Stockholder Equity | N/A | N/A | N/A | -642.14 million | N/A |
| Property, Plant & Equipment | N/A | N/A | N/A | 642.24 million | N/A |
| Total Current Assets | 1.36 billion | 1.29 billion | 1.23 billion | 1.58 billion | 1.58 billion |
| Long Term Investments | N/A | N/A | N/A | N/A | N/A |
| Net Tangible Assets | N/A | N/A | N/A | N/A | N/A |
| Short Term Investments | N/A | N/A | N/A | N/A | N/A |
| Long Term Debt | 2.2 billion | 2.19 billion | 2.22 billion | 2.51 billion | 2.51 billion |
| Inventory | 564.82 million | 536.05 million | 556.71 million | 561.68 million | 561.68 million |
| Accounts Payable | 330.25 million | 306.31 million | 298.99 million | N/A | 368 million |
Colfax Corporation (CFXA) Chart:
Colfax Corporation (CFXA) News:
Below you will find a list of latest news for Colfax Corporation (CFXA) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Colfax Corporation (CFXA) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|
Colfax Corporation (CFXA) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|